Accepted for/Published in: JMIR Research Protocols
Date Submitted: Feb 21, 2025
Open Peer Review Period: Feb 24, 2025 - Apr 21, 2025
Date Accepted: Apr 10, 2025
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Design of The Middle East African Registry for Women's CardioVascular Disease (MEA-WCVD)
ABSTRACT
Background:
The escalating incidence of cardiovascular disease (CVD) in the general population, particularly among women, has resulted in increased morbidity and mortality in the Middle East and African (MEA) Regions. Despite this concerning tendency, women remain significantly underrepresented in cardiovascular research, with no large-scale prospective multicenter trials reflecting national data published to date. To address this gap, we initiated the "Women CardioVascular Disease Middle East African Registry (MEA-WCVD)" to establish a comprehensive database on the contemporary epidemiological profile and management of Heart Failure (HF), Atrial fibrillation (AF), ischemic heart disease (IHD) and Valvular Heart disease (VHD) in women.
Objective:
This study aims to compare the management of cardiovascular diseases in women and men in a MEA countries sample, according to the current practice guidelines and encompass the identification of gender-based disparities, specifically examining healthcare insurance, income, and access to healthcare services.
Methods:
This prospective observational study involves a one-shot visit where patients diagnosed with HF, AF, IHD, or VHD provide informed consent, and their data are collected in a centralized certified database. The registry spans 75 days, with plans for an extended protocol to assess 1-year clinical outcomes.
Results:
The study's findings, expected at the conclusion, will include a comprehensive evaluation of the demographic profile and care management practices for the most prevalent cardiovascular diseases in women worldwide, aligned with current guidelines. The MEA-WCVD registry is anticipated to become the largest database for Middle East African patients monitored for HF, AF, IHD, and VHD.
Conclusions:
The MEA-WCVD registry will provide unique and necessary data on the management and outcomes of the most common CV diseases (AF, HF, IHD and VHD) while comparing standard care management in women to men in MEA regions. This study will yield the largest contemporary cohort of patients with cardiovascular diseases in MEA countries and would provide valuable answers about real-world cardio-vascular clinical epidemiology and management.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.